First round | Second round | Third round | |
Uptake | |||
Total | 55.0 | 53.0 | 55.3 |
Males | 50.4 | 48.7 | 51.0 |
Females | 59.5 | 57.1 | 59.6 |
Response to first kit | 43.8 | 51.5 | 53.7 |
Non-responders in all previous rounds | – | 13.8 | 13.9 |
Responders in any previous round | – | 85.4 | 85.2 |
Positivity rate | |||
Total | 2.07 | 1.90 | 1.16 |
Males | 2.83 | 2.56 | 1.52 |
Females | 1.44 | 1.36 | 0.86 |
Non-responders in all previous rounds | – | 2.56 | 1.58 |
Responders in any previous round | – | 1.88 | 1.10 |
The differences between males and females in all rounds and in both parameters were statistically significant at the p<0.001 level and the decline of the positivity rate was statistically significant at the p<0.01 level (χ2 test).